CA-AG v. Mallinckrodt

Mallinckrodt allegedly violated state and federal laws by knowingly underpaying Medicaid drug rebates for its drug H.P. Acthar Gel (Acthar) from January 2013 through June 2020. Mallinckrodt allegedly trimmed the actual amount the company owed the states under the Medicaid Drug Rebate Program by misreporting key pricing information to Medicaid and Medi-Cal for its drug Acthar. Mallinckrodt allegedly misreported key date and AMP-based pricing information, denying California and other states tens of millions of dollars in rebates.

Summary generated from official California Attorney General press release